USFDA grants Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis therapy
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Collaboration in the industry needs to be institutionalised to drive the growth.
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
he financing was significantly oversubscribed with high demand from both existing and new investors.
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Subscribe To Our Newsletter & Stay Updated